Pyxis Oncology, Inc.

NASDAQ:PYXS

1.2 (USD) • At close July 2, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 12.75919.47312.05625.07429.43911.13614.71525.89853.059179.293198.538223.355247.087274.735133.477142.473-8.088.08-19.69
Short Term Investments 92.673107.458132.762130.65129.06109.634118.252116.76596.29000000016.16039.38
Cash and Short Term Investments 105.432126.931144.818155.724158.499120.77132.967142.663149.349179.293198.538223.355247.087274.735133.477142.4738.088.0819.69
Net Receivables 000080.0210000.598000000000
Inventory 0000000006.34000000000
Other Current Assets 6.4395.5096.6285.3147.3525.2856.1276.6416.8336.7214.273.244.173.9381.7180.47100.0230
Total Current Assets 111.871132.44148.868161.038172.379124.604139.094149.304156.182186.612202.808226.595251.257278.673134.336142.9448.088.10319.69
Non-Current Assets:
Property, Plant & Equipment, Net 21.45222.14122.82423.67624.11124.81425.30425.92626.62124.76721.08715.9680.9951.2391.5421.85401.9390
Goodwill 0000000000000000000
Intangible Assets 2.5442.623.61923.67523.7324.30822.294000000000000
Goodwill and Intangible Assets 2.5442.623.61923.67523.7324.30822.294000000000000
Long Term Investments 0000000000000000000
Tax Assets 0000000000000000000
Other Non-Current Assets 0000000000000.4490.1093.612.251-8.080.109-19.69
Total Non-Current Assets 23.99624.74146.44347.35147.84149.12247.59825.92626.62124.76721.08715.9681.4441.3485.1524.105-8.082.048-19.69
Total Assets 135.867157.181195.311208.389220.22173.726186.692175.23182.803211.379223.895242.563252.701280.021139.488147.049010.1510
Liabilities & Equity:
Current Liabilities:
Account Payables 2.8464.8594.875.472.2933.8963.311.3054.0257.0975.5097.822.05511.9511.9271.26601.0770
Short Term Debt 1.5082.91.3932.6761.022.4642.4081.0541.21300000.1650.650.48100.6150
Tax Payables 000000000000000000.0640
Deferred Revenue 000-11.42707.667.1890000006.3265.4622.23701.9450
Other Current Liabilities 7.2311.37114.0578.75110.82811.73914.2216.8666.36324.53713.5867.09617.1326.59214.266.66501.9330
Total Current Liabilities 14.4317.6820.3216.89714.14125.75928.3329.22511.60131.63419.09514.91619.18718.70816.8378.41203.6890
Non-Current Liabilities:
Long Term Debt 18.33418.7519.14719.53419.75920.09920.41420.7319.03918.92116.05315.681000000.1650
Deferred Revenue Non-Current 0000-2.1642.1640000000000000
Deferred Tax Liabilities Non-Current 002.1642.1642.1642.1640000000000000
Other Non-Current Liabilities 00000000000000194.09196.225021.9420
Total Non-Current Liabilities 18.33418.7521.31121.69821.92322.26320.41420.7319.03918.92116.05315.6812.05512.116194.09196.225022.1070
Total Liabilities 32.76436.4341.63138.59536.06448.02248.74629.95530.6450.55535.14830.59719.18718.708210.927204.637025.7960
Equity:
Preferred Stock 0000000000000021.942172.08121.94221.94221.942
Common Stock 0.0620.060.0590.0590.0590.0450.0440.0390.0370.0340.0320.0320.0320.0320.0020.00200.0010
Retained Earnings -384.714-363.556-327.985-306.782-289.481-286.225-270.628-247.579-231.678-212.435-176.334-148.66-123.098-91.718-74.889-60.7140-15.7430
Accumulated Other Comprehensive Income/Loss 0.0490.170.351-0.102-0.060.063-0.105-0.0850.6960000-0-21.9420-15.6450-2.874
Other Total Stockholders Equity 487.706484.077481.255476.619473.638411.821408.635392.9383.108373.225365.049360.594356.58352.999197.471-168.9570-21.8450
Total Shareholders Equity 103.103120.751153.68169.794184.156125.704137.946145.275152.163160.824188.747211.966233.514261.313-71.439-57.5886.297-15.64519.068
Total Equity 0120.751153.68169.794184.156125.704137.946145.275152.163160.824188.747211.966233.514261.313-71.439-57.5886.297-15.64519.068
Total Liabilities & Shareholders Equity 135.867157.181195.311208.389220.22173.726186.692175.23182.803211.379223.895242.563252.701280.021139.488147.0496.29710.15119.068